SEC Form D private-offering filing

Cadrenal Therapeutics, Inc.

Name: Cadrenal Therapeutics, Inc. - new SEC Form D private-offering filing, Ponte Vedra, FL
Published: 2026-04-06

A new SEC Form D private-offering notice from Ponte Vedra, FL, a $7,923,235 filer-stated offering target in Biotech. The source filing is one click away.

Cadrenal Therapeutics, Inc. site↗ Verified via SEC Form D

Late stage biopharmaceutical company developing therapies for life threatening immune and thrombotic conditions, focused on anticoagulation and blood clotting disorders

Filed 2026-04-06Filed to raise $7,923,235First money in 2026-04-01Raised so far $7,923,235HQ (as filed) Ponte Vedra, FLSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified cadrenal.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Florida →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.